• Small Molecules
      • Discovery
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Computational & Data Sciences

Data to decisions

Syngene’s computational and data sciences solutions enable informed decisions for research and development. We are an interdisciplinary group of scientists with expertise across computational biology, computational chemistry, data sciences and research informatics. We help resolve complex problems of drug discovery from target identification, hit identification to lead optimization and translational insights.

Drug-discovery-pipeline

  • We provide end-to-end solutions across the drug discovery development pipeline for all your informatics needs.
  • Our services are accessible as standalone solutions or as part of an integrated project encompassing target identification and validation, integrated drug discovery (IDD), antibody engineering and multiomics analysis. We have capabilities across discovery biology (computational biology), discovery chemistry (computational chemistry), clinical development, and safety assessment.
  • Our informatics solutions ensure all the project data is accessible in a secure manner to our collaborators to enable AI democratization and decision-making using artificial intelligence (AI) for drug discovery
  • Our proprietary platform solutions available for drug discovery include Syn.AITM (AI drug discovery and platform) and SarchitectTM (QSAR modelling). Both platforms are tuned for drug discovery in contrast to generic tuning capability provided by open-source platforms.

Our informatics solutions ensure all the project data is accessible in a secure manner to our collaborators to enable AI democratization and decision-making using artificial intelligence (AI) for drug discovery


Our Services

Integrative Data Analysis
Target Assessment
Repurposing
Systems Modeling
Molecular Modeling
Data Sciences & AI
  • Analysis of multi omics big data
  • Build analysis pipelines
  • Derive biological, translational insights
  • Identify biomarkers, targets, stratify patients
  • Target dossiers
  • Target safety assessment reports
  • Knowledgebases in area of interest
  • Custom target related services
  • New indication for a molecule
  • New therapeutic uses for a target
  • Rare, neglected diseases
  • Repositioning human to animal health
  • Disease models
  • Efficacy, toxicity simulations
  • Clinical trial simulations
  • Manufacturing processes
  • Drug design
  • Cheminformatics
  • Antibody engineering
  • Protein engineering
  • Data engineering & Analytics
  • Predictive modeling
  • Multiparameter optimization
  • Analytics and visualization platforms

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details